Biden told it will take two weeks to have definitive data on Omicron variant



By Susan Heavey

WASHINGTON, Nov 28 (Reuters) - The top U.S. infectious disease official, Dr. Anthony Fauci, told President Joe Biden on Sunday it will take about two weeks to have definitive information on the new coronavirus variant Omicron that has sparked new travel restrictions and shaken financial markets.

Biden, returning to Washington following the Thanksgiving holiday weekend, was briefed in person by his coronavirus response team on Sunday afternoon as officials expect the new variant to reach the United States despite an impending ban on travelers from Southern Africa, where it was first detected.

Fauci said he believes existing vaccines are likely to provide "a degree of protection against severe cases of COVID", and officials reiterated their recommendation for vaccinated Americans to get booster shots, according to a readout of the briefing.

Biden was due to update the public on the new variant and the U.S. response on Monday, the White House said.

Omicron Link which was first detected in Southern Africa, has now been confirmed in Australia, Belgium, Botswana, Britain, Denmark, Germany, Hong Kong, Israel, Italy, the Netherlands, France, South Africa, and the United States' neighbor to the north, Canada.

Earlier on Sunday, Fauci told ABC News' "This Week" that the new variant would "inevitably" reach the United States.

"It clearly is giving indication that it has the capability of transmitting rapidly. That's the thing that's causing us now to be concerned," he added on NBC.

U.S. officials were seeking more information from South Africa about the new variant. Health and Human Services Secretary Xavier Becerra spoke to South Africa Health Minister Joe Phaahla on Sunday, praising the country's transparency, according to a readout of the meeting.

Its appearance in the United States, where 30% of the population has not received a single dose of vaccine Link could threaten to undermine the nation's recovery nearly two years after COVID-19's emergence and further pressure local healthcare systems already taxed by the recent Delta variant.

Rising cases as colder weather forces more people indoors has also caused some hospital systems and U.S. states, including New York, to declare emergencies.

So far, nearly 782,000 people have died in the United States from COVID-19 since early 2020, the most of any country in the world, amid over 48 million infections, Reuters data show.

TRAVELERS BANNED, NOT FLIGHTS

The United States is joining other nations in seeking to block transmission by imposing travel restrictions.

Beginning at 12:01 a.m. ET (0501 GMT) on Monday, it will bar entry of nearly all foreign nationals who have been in any of eight southern African countries within the last 14 days and has warned Americans against traveling to those nations.

U.S. citizens and lawful U.S. permanent residents who have traveled to the countries will still be able to enter the United States and no new screening or tracing requirements have been introduced.

Flights by Delta Air Lines DAL.N and United Airlines UAL.O have continued Link from South Africa to the United States since the variant was discovered.

Fauci and other top officials said the sudden burst of cases made Omicron worrisome and it remained unclear how current vaccines or therapeutics could be impacted.

"We need more data there before we can say confidently that this is not a severe version of the virus, but we should find that out in the next couple weeks," outgoing National Institutes of Health Director Dr. Francis Collins told "Fox News Sunday."

Vaccine makers Pfizer/BioNTech PFE.N 22UAy.DE and Moderna MRNA.O have said they expect more information soon.

"We have to go through a couple of weeks yet of uncertainty," Moderna Chief Medical Officer Dr. Paul Burton told CNN, saying Omicron's transmissibility and severity were also still unknown along with current vaccines' effectiveness against it.

'CLARION CALL' FOR SHOTS

Fauci pressed Americans to continue to get COVID-19 vaccines and boosters while experts evaluate Omicron.

"This is a clarion call ... (to) get vaccinated," he told NBC.

The United States has recorded over 1.1 million new COVID-19 cases in the last 14 days, up 9% from the prior two weeks, Reuters data shows, with Michigan and Minnesota leading the nation in new cases, based on infections per 100,000 residents.

The proportion of COVID-19 tests coming back positive in New York state had doubled since last month to 4.23%, underscoring the need for vaccinations, Governor Kathy Hochul said in a statement.

"Cases are rising throughout New York State, and the new Omicron variant poses a very real threat to the progress we've made," Hochul said.

The variant could cast a pall over the rest of the U.S. holiday season and potentially impact companies' return-to-office plans.



EXPLAINER-How worried should we be about the Omicron variant?

Reuters COVID-19 Tracker: United States Link
Omicron coronavirus variant spreads: cases detected in
Netherlands, Denmark, Australia

GRAPHIC-COVID-19 vaccine global tracker Link



Writing by Susan Heavey; Additional reporting by Nandita Bose, Chris Gallagher, Joel Schectman, David Shepardson and Simon Lewis in Washington; and Matt Scuffham, Megan Davies, Peter Szekely and Nathan Layne in New York; Editing by Daniel Wallis and Stephen Coates

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.